Statistics for Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial.
Total visits
| views | |
|---|---|
| Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial. | 3 |
Total visits per month
| views | |
|---|---|
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 3 |
| September 2024 | 0 |
| October 2024 | 0 |
File Visits
| views | |
|---|---|
| Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS) study protocol for a phase 2b, multicenter, randomized.pdf | 14 |